Texas Oncology - DFW

Clinical research site in Grapevine, Texas

Part of US Oncology

As of July 2026, 4 paid clinical trials are recruiting at Texas Oncology - DFW in Grapevine, Texas. Active studies at this site cover conditions such as Advanced Non-Small Cell Lung Cancer, Breast Cancer and Breast Neoplasms. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Recruiting clinical trials at Texas Oncology - DFW (4)

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
34 locations incl. Phoenix
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221149·Phase 2, Phase 3·Recruiting·Listed Oct 2025
Apply to this trial

More research sites in Grapevine

Explore more

Paid clinical trials in Grapevine, TX · Texas clinical trials